Cronos Group Inc. (CRON) stock
CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3010% below fair value
$3.19−0.08 (-2.45%)
Close on Nov 17, 2026Market cap $1.18BP/E 15.9Yield –
Cronos pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Cronos's pe ratio was 17.3× on Nov 11, 2026, against 52.0× a year earlier. Over the last 3 years it ranged from 1.7× to 284.0×, with a median of 16.9×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 17.3× | −9.1 |
| 2025 | Dec 31, 2025 | 26.3× | −16.8 |
| 2021 | Jan 29, 2021 | 43.1× | +14.2 |
| 2020 | Dec 31, 2020 | 28.9× | – |
See a number that looks wrong?